•  
  •  
 

Document Type

Original Article

Abstract

Background; The prognostic impact of end-stage renal disease (ESRD) on individuals with COVID-19 is not yet well understood. Aim and objectives; to match spirometric changes in cases with end-stage renal illness who had or did not have covid 19. Subjects and methods: Patients were categorised as follows for this study: Twenty individuals with ESRD due to covid-19 infection (Group A). A over-all of 20 ESRD cases who tested adverse for covid-19 made up Group (B). The "control" (group C) individuals are those who are otherwise healthy Result there was no significant difference (p= 0.644) in the relation of forced expiratory volume in 1 second to pushed vital capacity (FEV1) between Post covid-19 group (FEV1/FVC scaled from 69 to 90%) and the Negative for covid-19 group (FEV1/FVC scaled from 69 to 80%; mean SD = 74.45 3.66%) and the Control group (FEV1/FVC scaled from 70.01 to Three months after COVID-19 infection, the FVC, FEV1, and PEFR of ESRD patients receiving conventional HD were all considerably reduced. These findings provide support for a restricted pattern of pulmonary function after Covid in a large subset of individuals. There was no discernable variation in FVC/FEV1. Thus, there was no discernible variation in FVC/FEVI across the three groups. Conclusion; patients who underwent the Covid procedure after the study were free of obstructive pulmonary disease. In restrictive lung disease, the ratio does not improve; on the contrary, it improves.

Keywords

spirometric; hemodialysis; ESRD; post-covid-19; cases; end-stage renal illness.

Subject Area

Chest

Download

Share

COinS